Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 20Unknown 9Not yet recruiting 4Recruiting 3Terminated 2Active not recruiting 2

Sponsor Class

INDUSTRY 5OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Urologic Neoplasms 1Urogenital Neoplasms 1Penile Neoplasms 1Male Urogenital Diseases 1Esophageal Squamous Cell Carcinoma 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 332Specimen Handling 331Radiotherapy 315Cyclophosphamide 298pembrolizumab 286Cisplatin 270Carboplatin 247Drug Therapy 238Blood Specimen Collection 234Biopsy 203Bevacizumab 185Gemcitabine 181venetoclax 177Radiosurgery 170Oxaliplatin 164Capecitabine 163fludarabine 161Paclitaxel 158Nivolumab 157Standard of Care 135Surveys and Questionnaires 132Surgical Procedures, Operative 130Dexamethasone 126Fluorouracil 123Rituximab 113Docetaxel 112tislelizumab 111Cytarabine 106toripalimab 101Radiation 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × OTHER × CP protocol × Clear all
NCT06353906 2025-12-08

PRIAM

The Netherlands Cancer Institute

Phase 2 Recruiting
27 enrolled
Genitourinary

Penile Neoplasms, Urogenital Neoplasms, Urologic Neoplasms, Male Urogenital Diseases

NCT04460352 2025-03-06

NEEDS

Karolinska University Hospital

Phase 3 Recruiting
1,020 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04137653 2021-07-20

Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT

Shengjing Hospital

Phase 3 Recruiting
1,498 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡